Correction: Immunomodulator Clarithromycin Enhances Mucosal and Systemic Immune Responses and Reduces Re-Infection Rate in Pediatric Patients with Influenza Treated with Antiviral Neuraminidase Inhibitors: A Retrospective Analysis

There are errors in the last two sentences of the fourth paragraph of the Results section. The corrected sentence should read: ‘‘However, the proportions of children treated the previous year with OSV and ZNV who developed re-infection in 20092010 were significantly higher at 37.3% and 57.5%, respectively (P,0.01), than those of the no-treatment group. The combination treatment of CAM plus OSV and CAM plus ZNV tended to reduce the re-infection rate to 17.6% and 33.3%, respectively, albeit insignificantly.’’